Perioperative Prophylaxis in Pediatric Solid Organ Transplantation: A Baseline Stewardship Audit Using Routine Electronic Data
Transplant Infectious Disease · 2026
DOI: 10.1111/tid.70266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant Infectious Disease, 2026. Verfasst von Charles B Foster und 3 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pediatric Infectious Diseases, Cleveland Clinic Children's, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Antibiotic Prophylaxis, Organ Transplantation, Anti-Bacterial Agents, Antimicrobial Stewardship. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Cleveland Clinic Healthcare Delivery & Implementation Science Center.
Abstract (Originalsprache)
Background
Perioperative antibacterial prophylaxis in pediatric solid organ transplantation varies by center in regimen, add‐on agents, and stop dates. We used institutional protocols as a unified reference standard to establish baseline stewardship measures and targets for future quality‐improvement work.
Methods
We retrospectively evaluated 164 pediatric transplants from 2010 to 2021. Using anesthesia timing and medication‐administration data, we assessed on‐time dosing, regimen selection, MRSA‐ and VRE‐directed add‐on agents, double anaerobic coverage, Gram‐negative broadening during the protocol window, and discontinuation at organ‐specific stop targets. We also used transplant‐day anchoring and protocol‐defined windows to describe whether primary‐admission broad‐spectrum exposure represented protocol‐linked prophylaxis or later exposure. The audit measured protocol concordance and exposure patterns, not the appropriateness of deviations.
Results
Prophylaxis was given on time in 95.7% of procedures. Overall, 87.2% received the recommended initial regimen, 7.3% the protocol‐defined beta‐lactam allergy regimen, and 4.3% another broad Gram‐negative regimen. Only 61.0% stopped the main regimen by the intended cutoff; stop performance was best in kidney transplantation and poorest in intestinal and multivisceral transplantation. MRSA‐directed add‐ons clustered in intestinal and multivisceral procedures and often extended beyond the intended duration. A secondary descriptive analysis identified contiguous protocol‐linked continuation beyond the intended window in 8.6% of primary‐admission broad‐spectrum days of therapy.
Conclusions
Timing and initial regimen selection were strong. The main baseline process measure requiring prospective review was continuation of protocol‐linked antibiotics beyond cutoffs in abdominal transplantation. This audit shows how routine electronic data can be used to create reproducible measures and organ‐specific targets for future stewardship and quality‐improvement studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Section of Pediatric Infectious Diseases, Cleveland Clinic Children's, Cleveland, Ohio, USA.
- Pharmacy, Cleveland Clinic, Cleveland, Ohio, USA.
- Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA.
Förderung
- Cleveland Clinic Healthcare Delivery & Implementation Science Center
Zitieren
APA
Foster, C. B., Rivard, K., Arakoni, V. A., & Gonzalez, B. E. (2026). Perioperative Prophylaxis in Pediatric Solid Organ Transplantation: A Baseline Stewardship Audit Using Routine Electronic Data. Transplant Infectious Disease. https://doi.org/10.1111/tid.70266
Vancouver
Foster CB, Rivard K, Arakoni VA, Gonzalez BE. Perioperative Prophylaxis in Pediatric Solid Organ Transplantation: A Baseline Stewardship Audit Using Routine Electronic Data. Transplant Infectious Disease. 2026. doi:10.1111/tid.70266
BibTeX
@article{Foster2026,
author = {Foster, Charles B and Rivard, Kaitlyn and Arakoni, Venkatraman A and Gonzalez, Blanca E},
title = {Perioperative Prophylaxis in Pediatric Solid Organ Transplantation: A Baseline Stewardship Audit Using Routine Electronic Data},
journal = {Transplant Infectious Disease},
year = {2026},
doi = {10.1111/tid.70266}
}
EUVIMED